Clinical Trial Update: Aripiprazole in Children and Adolescents With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial results for aripiprazole in children and adolescents with Bipolar I Disorder have been posted (results posted on 2012-05-21).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-05-21